Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:ABBV
AbbVie
|
161.72 | -20.82% | -10.35% | 286,349.03 | 3.81% | 7.03% |
|
NasdaqGS:AMGN
Amgen
|
277.37 | -1.15% | 8.77% | 148,774.49 | 3.29% | 5.31% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
65.51 | 25% | 34.57% | 81,688.96 | 4.72% | 0.15% |
|
NasdaqGM:ALXN
Alexion Pharmaceuticals
|
182.50 | 0% | 0% | 40,336.01 | 0% | 0% |
|
NasdaqGS:BIIB
Biogen
|
216.13 | -9.56% | 6.49% | 31,467.86 | 0% | -10.89% |
|
NasdaqGS:BMRN
BioMarin Pharmaceutical
|
83.33 | 135.51% | 212.74% | 15,822.68 | 0% | 32.46% |
|
NasdaqGS:INCY
Incyte
|
52.94 | 106.98% | 155.97% | 11,887.19 | 0% | 27.62% |
|
NasdaqCM:VKTX
Viking Therapeutics
|
76.43 | 0% | 0% | 8,775.14 | 0% | 0% |
|
NasdaqGM:ARNA
Arena Pharmaceuticals
|
99.99 | 0% | 0% | 6,165.32 | 0% | 0% |
|
NasdaqGS:BPMC
Blueprint Medicines
|
94.86 | 0% | 0% | 5,737.51 | 0% | 0% |
|
NasdaqGS:CCXI
ChemoCentryx
|
51.99 | 0% | 0% | 3,739.11 | 0% | 0% |
|
NasdaqGS:CBAY
CymaBay Therapeutics
|
32.44 | 0% | 0% | 3,724.47 | 0% | 0% |
|
NasdaqGM:IOVA
Iovance Biotherapeutics
|
12.50 | 0% | 0% | 3,296.42 | 0% | 0% |
|
NasdaqGM:DRNA
Dicerna Pharmaceuticals
|
38.01 | 0% | 0% | 2,986.1 | 0% | 0% |
|
NasdaqGM:FOLD
Amicus Therapeutics
|
10.43 | 0% | 0% | 2,958.8 | 0% | 0% |
|
NasdaqGS:ACAD
ACADIA Pharmaceuticals
|
17.05 | 0% | 0% | 2,760.55 | 0% | 0% |
|
NasdaqCM:CLDX
Celldex Therapeutics
|
39.35 | 0% | 0% | 2,466.37 | 0% | 0% |
|
NasdaqGM:VCEL
Vericel
|
47.08 | -94.47% | -74.71% | 2,215.07 | 0% | 0% |
|
NasdaqGS:AGIO
Agios Pharmaceuticals
|
33.66 | 0% | 0% | 1,845.12 | 0% | 0% |
|
NasdaqGM:ADMA
ADMA Biologics
|
6.67 | 0% | 0% | 1,511.15 | 0% | 0% |
